Endurant Capital Management’s Entellus Medical, Inc. Common Stock ENTL Stock Holding History

Endurant Capital Management’s Portfolio ENTL Stock Details ENTL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-189,268	Closed	-$4.62M	–	90
2017 Q4	$4.62M	Sell	189,268 -19,503	-9%	-$375K	1.41%	32
2017 Q3	$3.85M	Buy	208,771 +130,171	+166%	+$2.25M	1.17%	29
2017 Q2	$1.3M	Buy	+78,600	New	+$1.09M	0.37%	60

Endurant Capital Management's ENTL Position: Q1 2018 in Review

Endurant Capital Management sold out of Entellus Medical, Inc. Common Stock (ENTL) in Q1 2018, closing a stake of 189,268 shares — an estimated $4.62M sold.

Endurant Capital Management first reported a position in ENTL in Q2 2017 and held it in 3 quarters. The position peaked at $4.62M in Q4 2017. 0 funds tracked by Wall St. Rank hold ENTL as of Q1 2018.

Endurant Capital Management reported no remaining Entellus Medical, Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Endurant Capital Management sold 189,268 Entellus Medical, Inc. Common Stock shares in Q1 2018, an estimated $4.62M.
Endurant Capital Management first reported a position in Entellus Medical, Inc. Common Stock in Q2 2017 and held it in 3 quarters.
Endurant Capital Management's Entellus Medical, Inc. Common Stock position peaked at $4.62M in Q4 2017.
0 funds tracked by Wall St. Rank held Entellus Medical, Inc. Common Stock as of Q1 2018.

Based on Endurant Capital Management's 13F filing for Q1 2018, filed 15 May 2018.